Page last updated: 2024-09-04

cyc 202 and ldc4297

cyc 202 has been researched along with ldc4297 in 3 studies

Compound Research Comparison

Studies
(cyc 202)
Trials
(cyc 202)
Recent Studies (post-2010)
(cyc 202)
Studies
(ldc4297)
Trials
(ldc4297)
Recent Studies (post-2010) (ldc4297)
9797393808

Protein Interaction Comparison

ProteinTaxonomycyc 202 (IC50)ldc4297 (IC50)
Cyclin-dependent kinase 1Homo sapiens (human)0.053
Cyclin-dependent kinase 2Homo sapiens (human)0.0064
Cyclin-dependent kinase 7Homo sapiens (human)0.0034
Cyclin-dependent kinase 9Homo sapiens (human)1.711

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (66.67)24.3611
2020's1 (33.33)2.80

Authors

AuthorsStudies
Cui, S; Galons, H; Huang, Y; Ingarra, AM; Li, T; Lu, K; Oumata, N; Teng, Y; Yu, P; Zhang, Q; Zhao, L1
Bharate, SB; Raghuvanshi, R1
Albert, T; Antrecht, C; Baumgart, K; Eickhoff, J; Kelso, TW; Klebl, B; Lemcke, S; Meisterernst, M1

Reviews

1 review(s) available for cyc 202 and ldc4297

ArticleYear
Recent advances in the development of cyclin-dependent kinase 7 inhibitors.
    European journal of medicinal chemistry, 2019, Dec-01, Volume: 183

    Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Cell Survival; Cyclin-Dependent Kinase-Activating Kinase; Cyclin-Dependent Kinases; Drug Development; Humans; Protein Kinase Inhibitors; Pyrimidines; Triazines

2019

Other Studies

2 other study(ies) available for cyc 202 and ldc4297

ArticleYear
Recent Developments in the Use of Kinase Inhibitors for Management of Viral Infections.
    Journal of medicinal chemistry, 2022, 01-27, Volume: 65, Issue:2

    Topics: Antiviral Agents; COVID-19; COVID-19 Drug Treatment; Drug Approval; Drug Repositioning; High-Throughput Screening Assays; Humans; Protein Kinase Inhibitors; SARS-CoV-2; United States; United States Food and Drug Administration; Virus Diseases

2022
Cyclin-dependent kinase 7 controls mRNA synthesis by affecting stability of preinitiation complexes, leading to altered gene expression, cell cycle progression, and survival of tumor cells.
    Molecular and cellular biology, 2014, Oct-01, Volume: 34, Issue:19

    Topics: Apoptosis; Cell Cycle; Cell Line, Tumor; Cyclin-Dependent Kinase-Activating Kinase; Cyclin-Dependent Kinases; Dose-Response Relationship, Drug; Gene Expression Regulation, Neoplastic; HEK293 Cells; HeLa Cells; Humans; Neoplasms; Phosphorylation; Protein Kinase Inhibitors; Purines; Pyrazoles; Pyrimidines; RNA Polymerase II; RNA, Messenger; Roscovitine; Triazines

2014